Pharma Journalist -

VERTANICAL said the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to VER-01, the company’s investigational non-opioid treatment for chronic low back…
Read More...

Owkin has entered into a new multi-year agreement with AstraZeneca to develop specialized artificial intelligence agents designed to support biopharmaceutical decision-making and…
Read More...

AstraZeneca announced positive interim results from the Phase III VOLGA clinical trial, showing that perioperative treatment with Imfinzi combined with neoadjuvant enfortumab vedotin…
Read More...

Arna Pharma Inc. and Slate Run Pharmaceuticals have officially finalized a joint venture aimed at creating a larger U.S.-based specialty pharmaceutical company focused on branded…
Read More...

Bristol Myers Squibb and Hengrui Pharma have entered into a broad strategic collaboration and licensing agreement focused on developing innovative medicines across oncology, hematology,…
Read More...

Pfizer Inc. announced that the European Commission has approved an expanded indication for HYMPAVZI, allowing its use in patients aged 12 years and older with hemophilia A or hemophilia…
Read More...

Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. announced updated clinical data from the frontline arm of the Phase 1 KOMET-007 trial evaluating Ziftomenib in combination with intensive…
Read More...

Assertio Holdings, Inc. announced that its Board of Directors has approved a definitive agreement for Zydus Lifesciences Limited, through its subsidiary Zydus Worldwide DMCC, to acquire…
Read More...

Zai Lab Limited announced that the U.S. Food and Drug Administration has granted Fast Track Designation to Zocilurtatug pelitecan, also known as zoci and formerly identified as ZL-1310,…
Read More...

Isomorphic Labs announced that it has secured $2.1 billion in Series B financing to expand its artificial intelligence-powered drug discovery and development platform, marking one of…
Read More...